A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer

Annals of Oncology

Volumn 26, Issue 4, 2015, Pages 762-768

  Lim, S H ^a   Lee, J Y ^a   Lee, M Y ^a   Kim, H S ^a   Lee, J ^a   Sun, J M ^a   Ahn, J S ^a   Um, S W ^a   Kim, H ^a   Kim, B S ^a   Kim, S T ^a   Na, D L ^a   Sun, J Y ^a   Jung, S H ^a,b   Park, K ^a   Kwon, O J ^a   Lee, J I ^a   Ahn, Myung Ju ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asymptomatic brain metastasis; NSCLC; Stereotactic radiosurgery (SRS)

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; PACLITAXEL; PEMETREXED;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN METASTASIS; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NON SMALL CELL LUNG CANCER; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VERY ELDERLY; BRAIN NEOPLASMS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COMPARATIVE STUDY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RADIOSURGERY; SECONDARY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOSURGERY; SURVIVAL RATE;

EID: 84926489999     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu584     Document Type: Article

References (29)

1. Shi AA, Digumarthy SR, Temel JS et al. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol 2006; 1: 205-210.
2. Kim SY, Kim JS, Park HS et al. Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients. J Korean Med Sci 2005; 20: 121-126.
3. Gaspar L, Scott C, Rotman M et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-751.
4. Gerosa M, Nicolato A, Foroni R et al. Regional treatment of metastasis: role of radiosurgery in brain metastases-gamma knife radiosurgery. Ann Oncol 2004; 15(Suppl 4): iv113-iv117.
5. Aoyama H, Shirato H, Tago M et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295: 2483-2491.
6. Tsao MN, Rades D, Wirth A et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012; 2: 210-225.
7. Sanchez de Cos J, Sojo Gonzalez MA, Montero MV et al. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors. Lung Cancer 2009; 63: 140-145.
8. Hochstenbag MM, Twijnstra A, Hofman P et al. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer 2003; 42: 189-193.
9. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
10. Lee JY, Dong Woo L, Cho SJ et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008; 21: 104-110.
11. Kang YND, Hahn S. A validity study on the Korean mini-mental state examination (K-MMSE) in dementia patients. J Kor Neurol Assoc 1997; 15: 300-308.
12. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
13. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14: 61-65.
14. Richards SH, Peters TJ, Coast J et al. Inter-rater reliability of the Barthel ADL index: how does a researcher compare to a nurse? Clin Rehabil 2000; 14: 72-78.
15. Kung-Yee Liang SLZ. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
16. Sperduto PW, Kased N, Roberge D et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012; 30: 419-425.
17. Network. NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guideline). Central Nervous System cancers. Version 1. 2014.
18. Kocher M, Soffietti R, Abacioglu U et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011; 29: 134-141.
19. Tsao M, Xu W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 2012; 118: 2486-2493.
20. Lee DH, Han JY, Kim HT et al. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first: result of a randomized pilot study. Cancer 2008; 113: 143-149.
21. Kim KH, Lee J, Lee JI et al. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases? Lung Cancer 2010; 68: 258-263.
22. Schiller JH, Harrington D, Belani CP et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92-98.
23. Yatabe Y. EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev 2010; 29: 23-36.
24. Scagliotti GV, Parikh P, von Pawel J et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 3543-3551.
25. Moscetti L, Nelli F, Felici A et al. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. Cancer 2007; 109: 274-281.
26. Scagliotti GV, De Marinis F, Rinaldi M et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002; 20: 4285-4291.
27. Peterson AM, Meltzer CC, Evanson EJ et al. MR imaging response of brain metastases after gamma knife stereotactic radiosurgery. Radiology 1999; 211: 807-814.
28. Banfill KE, Bownes PJ, St Clair SE et al. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival. Br J Neurosurg 2012; 26: 674-678.
29. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006; 64: 898-903.